TY - JOUR T1 - Sp1 Regulates Cathepsin B Transcription and Invasiveness in Murine B16 Melanoma Cells JF - Anticancer Research JO - Anticancer Res SP - 3887 LP - 3892 VL - 24 IS - 6 AU - ANNA M. SZPADERSKA AU - SIMONE SILBERMAN AU - YASMIN AHMED AU - ALLEN FRANKFATER Y1 - 2004/11/01 UR - http://ar.iiarjournals.org/content/24/6/3887.abstract N2 - Background: Increased expression of cathepsin B contributes to extracellular matrix degradation and invasion in cancer. Cathepsin B expression is under transcriptional control in murine melanomas and the major promoter contains potential binding sites for the Sp1 transcription factor. Materials and Methods: Murine melanoma cells transfected with an Sp1 expression plasmid or its control were used in Matrigel invasion and cell motility assays in the presence or absence of the cathepsin B inhibitor, CA-074Me. Results: Transfection of B16F1 cells with the Sp1 expression plasmid resulted in a 2.5-to 5.3 -fold increase in cathepsin B specific activity and a 4.8-to 5.5-fold increase in invasiveness over the control, but had no effect on the movement of cells across an uncoated membrane. CA-074Me treatment resulted in significantly reduced Matrigel invasion without affecting cell motility. Conclusion: Sp1 can regulate the capacity of B16F1 cells to degrade a reconstituted extracellular matrix in part by regulating cathepsin B expression. Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved ER -